Augmented trial designs for evaluation of principal surrogates. - Wikidata - thesis-toulmin - TriplyDB

Augmented trial designs for evaluation of principal surrogates.

Augmented trial designs for evaluation of principal surrogates.

http://www.wikidata.org/entity/Q37025729

about

Evaluation and comparison of predictive individual-level general surrogates.An Introduction to Principal Surrogate Evaluation with the pseval Package.

P2860

Q41992194-50BB429B-03E5-479E-8BDB-98B82501B37A Q49513361-ABFB86B9-5BAB-4EDD-A3EE-C633E98A0388

P2860

Augmented trial designs for evaluation of principal surrogates.

http://www.wikidata.org/entity/Q37025729

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 28 January 2016

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Augmented trial designs for evaluation of principal surrogates.

@en

Augmented trial designs for evaluation of principal surrogates.

@nl

type

label

Augmented trial designs for evaluation of principal surrogates.

@en

Augmented trial designs for evaluation of principal surrogates.

@nl

prefLabel

Augmented trial designs for evaluation of principal surrogates.

@en

Augmented trial designs for evaluation of principal surrogates.

@nl

P1433

Q37025729-95274952-1C91-43AB-8481-EAC00330290E

P1476

Q37025729-CFC4DE45-5892-49E7-9CE9-745E222350EE

P2093

Q37025729-6D398A42-603E-4AFF-99DA-25B647B37CF9

P2860

Q37025729-12BFEB47-4243-4762-8F43-C87AFF5423EC

Q37025729-143C2FE8-EA71-485B-93E7-21DEA63888D4

Q37025729-1B458000-F76B-4014-8452-04EBF1D486EF

Q37025729-25E1B5E8-37E4-476A-8026-5C6BD4ABF3A1

Q37025729-260CE442-CC64-4136-940E-23F2524BF3CC

Q37025729-27A5E3A8-2566-40DB-80DA-209BC9BB9EA5

Q37025729-2F131F74-3B89-4FBF-9986-6824BD2EB7E1

Q37025729-4FBEE097-68EC-43E0-B774-7A3976517C34

Q37025729-5E359462-7BD0-4436-AD2E-C04678D6F4B0

Q37025729-5F5C9AC0-5DEC-478E-A3A6-F75C90A3CA03

P304

Q37025729-E48E50B1-F0D8-4FA8-92A4-4C1627F44D98

P31

Q37025729-A99768E7-0946-4424-9F30-45644323F223

P356

Q37025729-2763A5E1-F898-4609-B1FD-F583E31B3B0B

P433

Q37025729-72DD06A7-3FAF-468E-9E78-07AB387EDB4F

P478

Q37025729-2D6E573C-5AF4-4B7E-ACB9-434832B89525

P50

Q37025729-7BCDDE9E-252D-4657-9DA8-06D2BF46C7DE

P577

Q37025729-5DC17E15-7E91-416B-8C6F-6BD779E0F851

P698

Q37025729-E212E411-C05D-4162-99C9-D52F1345C59F

P932

Q37025729-05EF37EB-1CAC-4F71-ACC2-D79FC3314C91

P356

P1433

P1476

Augmented trial designs for evaluation of principal surrogates.

@en

P2093

Dean Follmann

http://www.w3.org/2001/XMLSchema#string

P2860

Comparing biomarkers as principal surrogate endpoints

Evaluating principal surrogate endpoints with time-to-event data accounting for time-varying treatment efficacy

Surrogacy assessment using principal stratification when surrogate and outcome measures are multivariate normal.

Sufficient conditions for concluding surrogacy based on observed data.

Principal stratification in causal inference

Fold rise in antibody titers by measured by glycoprotein-based enzyme-linked immunosorbent assay is an excellent correlate of protection for a herpes zoster vaccine, demonstrated via the vaccine efficacy curve.

Linezolid for treatment of chronic extensively drug-resistant tuberculosis.

Surrogacy marker paradox measures in meta-analytic settings

A bayesian approach to surrogacy assessment using principal stratification in clinical trials.

Linezolid Trough Concentrations Correlate with Mitochondrial Toxicity-Related Adverse Events in the Treatment of Chronic Extensively Drug-Resistant Tuberculosis.

P304

453-467

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/BIOSTATISTICS/KXV055

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

17

http://www.w3.org/2001/XMLSchema#string

P50

P577

2016-01-28T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26825099

http://www.w3.org/2001/XMLSchema#string

P932

4915608

http://www.w3.org/2001/XMLSchema#string